Covichem评分预测COVID-19疾病严重程度的诊断效用
本研究在急诊科连续纳入COVID-19患者,记录人口学、合并症、生命体征、氧需求及实验室结果,计算Covichem评分(阈值0.5)并评估其预测疾病严重程度、ICU入住及院内死亡的能力。结果显示重症患者中位Covichem评分显著高于非重症患者(0.170,IQR 0.298,n=300 vs 0.026,IQR 0.065,n=191;p<0.001)。以0.5为阈值,12.4%(61/491)患者被预测为重症,但AUC仅48.5%(敏感性18.1%,特异性93.8%);重新计算理想阈值后AUC达82%,敏感性79.9%,特异性71.2%。作者结论为该评分外部验证表现差于原推导与验证研究,即使采用新截断值亦如此。
要点
- 重症患者中位Covichem评分0.170(IQR 0.298,n=300)显著高于非重症0.026(IQR 0.065,n=191),p<0.001。
- 以0.5为阈值,12.4%(61/491)患者被预测为重症,AUC仅48.5%(敏感性18.1%,特异性93.8%)。
- 重新计算理想阈值后AUC达82%,敏感性79.9%,特异性71.2%。
- 外部验证中Covichem评分表现差于原推导与验证研究,即使采用新截断值亦如此。
适用人群与场景
- 连续纳入至急诊科就诊的COVID-19患者。
诊断标准与关键阈值
- Covichem评分阈值0.5用于预测重症;另计算新理想阈值。
研究设计与关键结果
- 研究类型为外部验证;纳入急诊科连续COVID-19患者,记录人口学、合并症、生命体征、氧需求及实验室结果,计算Covichem评分(阈值0.5)评估预测疾病严重程度、ICU入住及院内死亡的能力。
- 重症患者中位Covichem评分0.170(IQR 0.298,n=300) vs 非重症0.026(IQR 0.065,n=191),p<0.001。
- 以0.5为阈值,12.4%(61/491)患者被预测为重症;AUC 48.5%(敏感性18.1%,特异性93.8%)。
- 重新计算理想阈值后AUC达82%,敏感性79.9%,特异性71.2%。
证据类型、等级与局限
- 证据类型:外部验证研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:Covichem评分外部验证表现差于原推导与验证研究,即使采用新截断值亦如此。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Identifying which patients with COVİD-19 have a high risk of severe illness is essential to optimizing management and resource utilization strategies.
OBJECTIVES: The aim of this study was to externally validate the diagnostic utility of the Covichem score for predicting COVID-19 disease severity, and secondarily to evaluate its utility in predicting intensive care unit (ICU) admission, and in-hospital mortality.
METHODS: All consecutive COVID-19 patients who presented to the emergency department (ED) were included, and patients' demographic data, comorbidities, vital signs, oxygen requirement, and laboratory results were recorded. We calculated patients' Covichem scores and estimates (using a threshold of 0.5) and evaluated the utility of the Covichem score for predicting disease severity, ICU admission, and mortality.
RESULTS: The median Covichem score was significantly higher for patients with severe illness (Covichem score: 0.170, IQR: 0.298, n = 300 vs. Covichem score: 0.026, IQR: 0.065, n: 191; p < 0.001). Based on their Covichem scores, 12.4% (61/491) of the patients were predicted to experience severe illness (threshold: 0.5), the accuracy of the Covichem score was poor, as the area under curve (AUC) was 48.5% (18.1% sensitivity and 93.8% specificity). When we calculated a new ideal threshold, the AUC reached 82%, but the sensitivity was 79.9% and the specificity was 71.2%.
CONCLUSION: In this external validation of the Covichem score, we found that it performed worse than in the original derivation and validation study, even with the assistance of a new cutoff.
参考来源
- Ozpolat C, Altunbas E. Diagnostic utility of the Covichem score in predicting COVID-19 disease. Am J Emerg Med. 2022. PMID: 35905602. doi:10.1016/j.ajem.2022.07.025
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。